NCT04484064Recruiting
Optimization of the Targeted Anticancer Therapies
Summary
The study includes an observational pharmacokinetic study and an interventional medication adherence study. The purpose of this study is 1) to describe the concentration-time profiles of targeted anticancer drugs and to characterize the concentration-effect/toxicity relationships in the target population of patients (observational study) and 2) to characterize patterns of adherence to oral targeted anticancer drugs and identify key-driver modifiable adherence factors in patients participating in an adherence program (interventional study).
Inclusion criteria
• Cancer patients to whom a targeted anticancer therapy is prescribed
Exclusion criteria
• Patients incapable of judgment or participants under tutelage
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Recruiting
- Phase
- No phase (N/A)
- Study type
- Interventional
- Countries
- Switzerland
- Sponsor
- Centre Hospitalier Universitaire Vaudois(Other)
- Protocol no.
- CHUV-PCL-OpTAT-2015
- Conditions
- Cancer
- Interventions
- Behavioral
Treatments studied
- Adherence program
Collaborators
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland, Krebsforschung Schweiz, Bern, Switzerland
Locations · 1
- Lausanne, SwitzerlandCHUVRecruiting at this site
In total, worldwide, the only site listed in the registry is recruiting.
Site status per the ClinicalTrials.gov registry (last update posted: July 23, 2020).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
Other identifiers
- 65/15 · other identifier
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.